nonlinear mixed-effect modeling software nonmem version 7.1.0 Search Results


90
ICON plc linear mixed-effects model
Stepwise Minimum Objective Function Changes for <t> Linear Mixed‐Effects Model </t> for the Dependent Variables ΔΔQTc, ΔΔQTcF, or ΔΔQTcP
Linear Mixed Effects Model, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+mixed-effect+modeling+software+nonmem+version+7%2E1%2E0/linear+mixed+effects+model/pmc05049657-38-19-25
Average 90 stars, based on 1 article reviews
linear mixed-effects model - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ICON plc nonlinear mixed-effect modeling software nonmem version 7.1.0
Stepwise Minimum Objective Function Changes for <t> Linear Mixed‐Effects Model </t> for the Dependent Variables ΔΔQTc, ΔΔQTcF, or ΔΔQTcP
Nonlinear Mixed Effect Modeling Software Nonmem Version 7.1.0, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+mixed-effect+modeling+software+nonmem+version+7%2E1%2E0/nonlinear+mixed+effects+modeling+software+nonmem+version+7+4+4/pmc04335897-163-8-14
Average 90 stars, based on 1 article reviews
nonlinear mixed-effect modeling software nonmem version 7.1.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Stepwise Minimum Objective Function Changes for  Linear Mixed‐Effects Model  for the Dependent Variables ΔΔQTc, ΔΔQTcF, or ΔΔQTcP

Journal: Journal of Clinical Pharmacology

Article Title: Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil

doi: 10.1002/jcph.572

Figure Lengend Snippet: Stepwise Minimum Objective Function Changes for Linear Mixed‐Effects Model for the Dependent Variables ΔΔQTc, ΔΔQTcF, or ΔΔQTcP

Article Snippet: Linear regression models for olmesartan plasma concentrations and ΔΔQTc were assessed for the 2 olmesartan treatments using a linear mixed‐effects model in NONMEM (version 7.1.0; ICON plc, Ellicott City, Maryland).

Techniques:

Parameter Estimates for the  Linear Mixed‐Effects Model  for the Effect of Olmesartan Plasma Concentrations (OM conc ) and Baseline‐Corrected, Placebo‐Adjusted Heart Rate (ΔΔRR) on ΔΔQTc

Journal: Journal of Clinical Pharmacology

Article Title: Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil

doi: 10.1002/jcph.572

Figure Lengend Snippet: Parameter Estimates for the Linear Mixed‐Effects Model for the Effect of Olmesartan Plasma Concentrations (OM conc ) and Baseline‐Corrected, Placebo‐Adjusted Heart Rate (ΔΔRR) on ΔΔQTc

Article Snippet: Linear regression models for olmesartan plasma concentrations and ΔΔQTc were assessed for the 2 olmesartan treatments using a linear mixed‐effects model in NONMEM (version 7.1.0; ICON plc, Ellicott City, Maryland).

Techniques: Clinical Proteomics